IRWD — Ironwood Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $589.91m
- $895.78m
- $296.15m
Ironwood Pharmaceuticals Inc expected to post earnings of 25 cents a share - Earnings Preview
Brief: Ironwood And VectivBio Announce Expiration Of Hart-Scott-Rodino Waiting Period For Proposed Acquisition Of VectivBio
U.S. STOCKS ON THE MOVE-Rio Tinto, BurgerFi International, Aclaris Therapeutics
U.S. STOCKS ON THE MOVE-Comerica, copper miners, Journey Medical
U.S. STOCKS ON THE MOVE-Home Depot, Netflix, Bunge
Ironwood Pharma up as FDA approves expanded use of constipation drug
Brief: Ironwood Pharmaceuticals Announces FDA Approval Of New Indication For LINZESS
U.S. RESEARCH ROUNDUP-Cleveland-Cliffs, Graftech International, Steel Dynamics
Brief: Ironwood Pharmaceuticals Says If Deal Aborts, VectivBio To Pay Termination Fee
Brief: Ironwood Pharma To Acquire VectivBio For $1.15 Billion
VectivBio surges as Ironwood Pharma to buy co for $1.15 bln
Ironwood Pharma to acquire VectivBio for $1.15 bln (updated)
Ironwood Pharma to acquire Swiss-based VectivBio in $1 bln deal
Brief: Ironwood Presents New Data On Potential Of Linaclotide For Functional Constipation In
Ironwood Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Ironwood Pharmaceuticals Q1 Rev $104.1 Mln
Brief: Ironwood Pharmaceuticals Reports First Quarter 2023 Results Maintains Full Year 2023 Financial Guidance
Ironwood Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Ironwood Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary